Ashkar Samy

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

Mindmaze, Inc. operates as a computing platform that captures brain activity. The firm develops medical virtual reality products for neural sicknesses. The firm offers MindMotion PRO, is FDA-cleared to bring 3D virtual environment therapy for neuro rehabilitation to patients. The company was founded by Tej Tadi in 2012 and is headquartered in San Francisco, CA.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.

Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore.

MindMaze SA engages in the development of a neuro-inspired computing platform that captures brain activity upon intent, creating a new operating system for computers. It also engages in the use of virtual reality to rehabilitate the brains of stroke patients. The company was founded by Tej Tadi in 2012 and is headquartered in Lausanne, Switzerland.

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products.

Part of Interpublic Group of Cos., Inc., Migliara Kaplan & Associates is a full-service health care marketing company. The company is based in Owings Mills, MD. The company was founded by Joseph M. Migliara, Harris Kaplan. Migliara Kaplan & Associates was acquired by NFO Research, Inc. on January 09, 1996 for $15.20 million.

Noorik Biopharmaceuticals AG is a Swiss drug development company. The private company is based in Basel, Switzerland.